Report period | 2018 | 2019 | 2020 | 2021 | 2022 | Q1 23 |
---|---|---|---|---|---|---|
End date of the reporting period | ||||||
Capitalization, $ | ||||||
Capitalization, $ | ||||||
Enterprise Value | ||||||
Book Value | ||||||
Shareholders Book Value | ||||||
Current liabilities | ||||||
Noncurrent liabilities | ||||||
Total liabilities | ||||||
Debt | ||||||
Cash and cash equivalents | ||||||
Net debt | ||||||
Assets | ||||||
Total ordinary shares | ||||||
Ordinary share price |
Ticker | Name | Type | Nominal value | ISIN | Price |
---|---|---|---|---|---|
A:US | Agilent Technologies Inc | Common share | - | US00846U1016 | $140.9 |
Company name | Agilent Technologies |
---|---|
Tags | #s&p500 index |
Sector | Health Care / Pharmaceuticals, Biotechnology & Life Sciences / Life Sciences Tools & Services / Life Sciences Tools & Services |
Business address | 5301 STEVENS CREEK BLVD SANTA CLARA CA 95051 (408) 345-8886 |
Mailing address | 5301 STEVENS CREEK BLVD, MS 1A-LC P.O. BOX 58059 SANTA CLARA CA 95052-8059 |
Website | www.investor.agilent.com |
Information disclosure | www.sec.gov |